A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population

被引:5
|
作者
Hines, Laena [1 ]
Zhu, Denzel [2 ]
DeMasi, Matt [2 ]
Babar, Mustufa [2 ]
Chernyak, Victoria [2 ,3 ,4 ]
Kovac, Evan Z. [2 ,3 ]
Aboumohamed, Ahmed [2 ,3 ]
Sankin, Alex [2 ,3 ]
Agalliu, Ilir [2 ,3 ,5 ]
Watts, Kara L. [2 ,3 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
[2] Albert Einstein Coll Med, 1250 Waters Pl,Tower 1,Penthouse, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Dept Urol, 1250 Waters Pl,Tower 1,Penthouse, Bronx, NY 10461 USA
[4] Montefiore Med Ctr, Dept Radiol, Bronx, NY 10461 USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA
关键词
prostate; magnetic resonance imaging; biopsy; logistic models; prostatic neoplasms; CANCER;
D O I
10.1097/JU.0000000000001810
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: NonHispanic Black (NHB) and Hispanic/Afro-Caribbean men have the highest risk of prostate cancer (PCa) compared to nonHispanic White (NHW) men. However, ethnicity-specific outcomes of targeted fusion biopsy (FB) for the detection of PCa are poorly characterized. We compared the outcomes of FB by Prostate Imaging Reporting and Data System (PI-RADS (R)) score and race/ ethnicity among a diverse population. Materials and Methods: We evaluated all men who underwent image-guided FB for suspicious lesions on prostate magnetic resonance imaging (>= PI-RADS 3) over a 2-year period. We examined associations of race/ethnicity and PI-RADS score with risk of PCa or clinically significant PCa (cs-PCa, Gleason Group >= 2) on FB using mixed-effects logistic regression models. Results: A total of 410 men with 658 lesions were analyzed, with 201 (49.0%) identified as NHB and 125 (30.5%) identified as Hispanic. NHB men had a twofold increase in the odds of detecting cs-PCa (OR=2.7, p=0.045), while Hispanic men had similar odds of detecting cs-PCa compared to NHW men. With regard to all PCa, NHB men had a similar increase in the odds of detecting all PCa (OR=2.4, p=0.050), which was borderline statistically significant compared to NHW men on FB. When we excluded men on active surveillance, NHB men had even stronger associations with detection of cs-PCa (OR=3.10, p=0.047) or all PCa (OR=2.77, p=0.032) compared to NHW men. Conclusions: NHB men have higher odds for overall PCa and cs-PCa on FB compared to NHW men. Further work may clarify differences per PI-RADS score. Clinicians should interpret prostate magnetic resonance imaging lesions with more caution in NHB men.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 42 条
  • [21] Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results
    Tewes, Susanne
    Hueper, Katja
    Hartung, Dagmar
    Imkamp, Florian
    Herrmann, Thomas R. W.
    Weidemann, Juergen
    Renckly, Stefan
    Kuczyk, Markus A.
    Wacker, Frank
    Peters, Inga
    WORLD JOURNAL OF UROLOGY, 2015, 33 (11) : 1707 - 1714
  • [22] Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter
    Stavrinides, Vasilis
    Giganti, Francesco
    Allen, Clare
    Kirkham, Alex
    Punwani, Shonit
    Freeman, Alex
    Norris, Joseph
    Pashayan, Nora
    Moore, Caroline M.
    Embertonk, Mark
    JOURNAL OF UROLOGY, 2021, 205 (05) : 1526 - 1528
  • [23] Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?
    Myong Kim
    Hoyoung Ryu
    Hak Jong Lee
    Sung Il Hwang
    Gheeyoung Choe
    Sung Kyu Hong
    World Journal of Urology, 2021, 39 : 1463 - 1471
  • [24] The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy
    Mert Kilic
    Serdar Madendere
    Metin Vural
    Ersin Koseoglu
    Mevlana Derya Balbay
    Tarik Esen
    World Journal of Urology, 2023, 41 : 449 - 454
  • [25] The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy
    Kilic, Mert
    Madendere, Serdar
    Vural, Metin
    Koseoglu, Ersin
    Balbay, Mevlana Derya
    Esen, Tarik
    WORLD JOURNAL OF UROLOGY, 2023, 41 (02) : 449 - 454
  • [26] MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancer
    Dekalo, Snir
    Mazliah, Ohad
    Barkai, Eyal
    Bar-Yosef, Yuval
    Herzberg, Haim
    Bashi, Tomer
    Fahoum, Ibrahim
    Barnes, Sophie
    Sofer, Mario
    Yossepowitch, Ofer
    Keren-Paz, Gal
    Mano, Roy
    CANADIAN JOURNAL OF UROLOGY, 2024, 31 (04)
  • [27] Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate
    Liu, Yunyun
    Wang, Shuai
    Xu, Guang
    Zhou, Bangguo
    Zhang, Ying
    Ye, Beibei
    Xiang, Lihua
    Zhang, Yifeng
    Xu, Huixiong
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (03) : 709 - 717
  • [28] Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial
    Zhang, Jing
    Zhu, Aiyun
    Sun, Dingqi
    Guo, Shanjie
    Zhang, Hui
    Liu, Shuai
    Fu, Qiang
    Zhang, Keqin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (07) : 1698 - 1702
  • [29] Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3 T MR image-guided targeted biopsy
    Fedorov, Andriy
    Tuncali, Kemal
    Panych, Lawrence P.
    Fairhurst, Janice
    Hassanzadeh, Elmira
    Seethamraju, Ravi T.
    Tempany, Clare M.
    Maier, Stephan E.
    MAGNETIC RESONANCE IMAGING, 2016, 34 (08) : 1146 - 1154
  • [30] How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
    Yu Zhang
    Na Zeng
    FengBo Zhang
    YangXinRui Huang
    Ye Tian
    International Journal of Clinical Oncology, 2020, 25 : 175 - 186